New therapeutic strategies for eradication of Helicobacter pylori in children
10.3760/cma.j.issn.1673-4408.2016.12.001
- VernacularTitle:儿童中根除幽门螺杆菌新的治疗对策
- Author:
Yi CHEN
;
Jie CHEN
- Keywords:
Helicobacter pylori;
Eradication rate;
Sequential therapy;
Bismuth-based therapy;
Concomi-tant therapy;
Probiotics
- From:
International Journal of Pediatrics
2016;43(12):905-908,909
- CountryChina
- Language:Chinese
-
Abstract:
Helicobacter pylori is closely related to many digestive system diseases,such as chronic gas-tritis,digestive ulcer,gastric mucosa associated lymphoid tissue lymphoma and gastric cancer,also leads to chil-dren with iron deficiency anemia,growth retardation,asthma,allergic diseases etc. So it is a key strategy to pre-vent and treat these diseases by eradicating Helicobacter pylori. Due to the increasing rates of antimicrobial resist-ance of clarithromycin and metronidazole,the eradication rate of standard triple therapy is 1ess than 80%in re-cent years. Especially in areas of high clarithromycin resistance and standard triple therapy have not been recom-mended as first-line therapy,it is necessary to investigate a new therapeutic strategy to improve the eradication rate of Helicobacter pylori. The new treatments for eradication of Helicobacter pylori in children is mainly based on sequential therapy,bismuth-based therapy,concomitant therapy and probiotics treatment. This article reviews the research progress of the new treatments in recent years.